|Catalog No.||Product Name||Information||Selective / Pan||IC50 / Ki|
|S6636||Azaindole 1 (TC-S 7001)||
Azaindole 1 (TC-S 7001) is a selective Rho-associated protein kinase (ROCK) inhibitor with IC50 of 0.6 and 1.1 nM for human ROCK-1 and ROCK-2 in an ATP-competitive manner.
|Pan||ROCK1, IC50: 0.6 nM|
GSK269962A HCl (GSK269962B, GSK269962) is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.
|Pan||ROCK1, IC50: 1.6 nM|
AT13148 is an oral, ATP-competitive, multi-AGC kinase inhibitor with IC50 of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively. Phase 1.
|Pan||ROCK1, IC50: 6 nM|
GSK429286A (RHO-15) is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM, respectively.
|Pan||ROCK1, IC50: 14 nM|
RKI-1447 is a potent inhibitor of ROCK1 and ROCK2, with IC50 of 14.5 nM and 6.2 nM, respectively, has anti-invasive and antitumor activities.
|Pan||ROCK1, IC50: 14.5 nM|
|S7995||Ripasudil (K-115) hydrochloride dihydrate||
Ripasudil (K-115) hydrochloride dihydrate is potent ROCK inhibitor with IC50 of 51 nM and 19 nM for ROCK1 and ROCK2, respectively, used for the treatment of glaucoma and ocular hypertension.
|Pan||ROCK1, IC50: 51 nM|
Y-27632 2HCl is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM in a cell-free assay, exhibits >200-fold selectivity over other kinases, including PKC, cAMP-dependent protein kinase, MLCK and PAK.
|Pan||ROCK1 (p160ROCK), Ki: 140 nM|
|S8208||Hydroxyfasudil (HA-1100) HCl||
Hydroxyfasudil (HA-1100), an active metabolite of fasudil hydrochloride, is a specific Rho-kinase(ROCK) inhibitor with IC50 values of 0.73 μM and 0.72 μM for ROCK1 and ROCK2, respectively.
|Pan||ROCK1, IC50: 0.73 μM|
There are no products matching the selection yet, if you have any question please do not hesitate to contact us.